ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1345

The Impact of Prior Antibiotic Treatment on Culture Results of Patients with Septic Arthritis

Ziv Paz1, Sarah B. Lieber1, Andrew Moore2, Clara Zhu3, Mary Louise Fowler4 and Robert H. Shmerling5, 1Beth Israel Deaconess Medical Center, Boston, MA, 2Medicine, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, 3Medical School, Boston University School of Medicine, Boston, MA, 4School of Medicine, Boston University School of Medicine, Boston, MA, 5Medicine, Beth Israel Deaconess Medical Center, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Antibiotics, Arthritis, infection and synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Infection-related Rheumatic Disease: Poster Session

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Synovial fluid culture
and gram stain offer the most compelling proof of septic arthritis (SA); these
tests are indicated in every suspected case. However, the sensitivity and
specificity of these studies are not well established, especially among patient
who have received antibiotic administration prior to synovial fluid sampling.
The purpose of this study was to define the impact of prior antibiotic use on
synovial fluid gram stain and culture results among patients with septic
arthritis.

Methods:

We conducted a
retrospective cohort study of patients 18 years and older admitted to a single
tertiary care center from 1998 to 2015 with septic monoarthritis.  The diagnosis of SA was defined by typical clinical
presentation and positive blood culture, synovial gram stain and/or culture.  Patients were stratified by the timing of
antibiotic use with regard to joint aspiration and whether the involved joint
was native or prosthetic.

Results:

Of 338 patients with SA, 207 had native joint involvement.   The synovial fluid cultures were positive in
84.6% of cases while synovial fluid gram stain was positive in only 35%.  Prior antibiotic use was associated with a significant
reduction in synovial fluid culture positivity (90.5% without prior antibiotics
vs. 67.5% with prior antibiotics; p<0.01) (Tables 1 and 2). There was no
significant difference in the rate of gram stain positivity based on prior
antibiotic treatment although there was a trend toward fewer positive gram
stain results among those receiving prior antibiotics (Table 1).  

Conclusion:  

While it is well-known that prior antibiotic administration
may affect the results of synovial fluid culture and gram stain, this is one of
the few large studies that quantitate these effects.   We found the most dramatic impact of prior
antibiotic administration is a reduction of synovial fluid culture positivity.   Further analysis is ongoing to assess the
timing of prior antibiotic therapy on synovial fluid culture and gram stain
results in SA.


Disclosure: Z. Paz, None; S. B. Lieber, None; A. Moore, None; C. Zhu, None; M. L. Fowler, None; R. H. Shmerling, None.

To cite this abstract in AMA style:

Paz Z, Lieber SB, Moore A, Zhu C, Fowler ML, Shmerling RH. The Impact of Prior Antibiotic Treatment on Culture Results of Patients with Septic Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-impact-of-prior-antibiotic-treatment-on-culture-results-of-patients-with-septic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-prior-antibiotic-treatment-on-culture-results-of-patients-with-septic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology